{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:37:59Z","timestamp":1722991079901},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.leukres.2024.107543","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T15:50:46Z","timestamp":1718898646000},"page":"107543","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Post-transplant cyclophosphamide: A double-edged sword?"],"prefix":"10.1016","volume":"143","author":[{"given":"Alessandro","family":"Busca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2024.107543_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.seminoncol.2012.09.005","article-title":"Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical BMT","volume":"39","author":"Luznik","year":"2012","journal-title":"Semin Oncol."},{"issue":"18","key":"10.1016\/j.leukres.2024.107543_bib2","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.20.03502","article-title":"National marrow donor program-sponsored multicenter, phase ii trial of hla-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide","volume":"39","author":"Shaw","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.leukres.2024.107543_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.leukres.2024.107543_bib4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41409-023-02085-2","article-title":"Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation","volume":"58","author":"Dul\u00e9ry","year":"2023","journal-title":"Bone Marrow Transpl."},{"issue":"3","key":"10.1016\/j.leukres.2024.107543_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bjh.19228","article-title":"Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation","volume":"204","author":"Fuji","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.leukres.2024.107543_bib6","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.bbmt.2015.04.025","article-title":"Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells","volume":"21","author":"Cieri","year":"2015","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"14","key":"10.1016\/j.leukres.2024.107543_bib7","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1182\/bloodadvances.2023010545","article-title":"PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation","volume":"7","author":"Al-Homsi","year":"2023","journal-title":"Blood Adv."},{"journal-title":"Cancer","year":"2024","author":"Bazarbachi","key":"10.1016\/j.leukres.2024.107543_bib8"},{"issue":"25","key":"10.1016\/j.leukres.2024.107543_bib9","first-page":"3031","article-title":"Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia","volume":"141","author":"DeZern","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2024.107543_bib10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbmt.2014.08.014","article-title":"Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease","volume":"21","author":"Al-Homsi","year":"2015","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.leukres.2024.107543_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107530","article-title":"Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation","author":"Zulch","year":"2024","journal-title":"Leuk. Res"},{"issue":"5","key":"10.1016\/j.leukres.2024.107543_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clml.2016.02.004","article-title":"Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment","volume":"16","author":"Gergis","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"1","key":"10.1016\/j.leukres.2024.107543_bib13","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/S2352-3026(23)00305-8","article-title":"Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT\/ELN International Working Group","volume":"11","author":"Kr\u00f6ger","year":"2024","journal-title":"Lancet Haematol."},{"issue":"3","key":"10.1016\/j.leukres.2024.107543_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41409-023-02163-5","article-title":"Donor specific antibodies (DSA): the only risk factor for primary graft failure?","volume":"59","author":"Bacigalupo","year":"2024","journal-title":"Bone Marrow Transpl."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T08:03:53Z","timestamp":1722931433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624001097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":14,"alternative-id":["S0145212624001097"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107543","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-transplant cyclophosphamide: A double-edged sword?","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107530","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107543"}}